← Evidence map

ReviewInternational journal of endocrinology2025

Resmetirom: The First Disease-Specific Treatment for MASH.

Ali Mohamed Mousa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40212963